Tech
Gadgets
Mobile
Enterprise
CrunchBase
More
Beta Invites
Elevator Pitches
Gillmor Gang
Podcasts
TechCrunch50
TechCrunch UK
TechCrunch France
TechCrunch Japan
Advanced Search
Edits
|
Login
Browse:
Companies
|
People
|
Financial Organizations
Home
>
Companies
>
Bellicum Pharmaceuticals
edit
General Information
edit
Website
bellicum.com
Category
BioTech
Email
Employees
Founded
7/04
Description
Cancer, Infectious Disease Treatment
Offices
edit
People
edit
Kevin Slawin
Founder, President, CMO
Thomas J. Farrell
CEO
David M. Spencer
CSO
Funding
edit
Total
$8.25M
Seed, 10/07
$2.3M
Series A, 11/09
$4.5M
Grant, 10/07
The Texas Emerging Technology Fund
$1.45M
Tags
edit
Bellicum Pharmaceuticals
edit
No overview yet.
Milestones
edit
Bellicum Pharmaceuticals
received $4.5M in Series A funding. (11/4/09)
Posted 11/4/09 at 5:49pm
Bellicum Pharmaceuticals
received $1.45M in Grant funding. (10/9/07)
Posted 11/4/09 at 5:47pm
Bellicum Pharmaceuticals
received $2.3M in Seed funding. (10/9/07)
Posted 11/4/09 at 5:47pm
Bellicum Pharmaceuticals
added
Kevin Slawin
as Founder, President, CMO. (7/04)
Posted 11/4/09 at 5:47pm
Bellicum Pharmaceuticals
added
Thomas J. Farrell
as CEO.
Posted 11/4/09 at 5:47pm
Bellicum Pharmaceuticals
added
David M. Spencer
as CSO.
Posted 11/4/09 at 5:47pm
Videos
Screenshots
edit
Sources
BELLICUM PHARMACEUTICALS ANNOUNCES $3.75 MILLION IN FINANCING
(bellicum.com) [
edit
]
BELLICUM PHARMACEUTICALS ANNOUNCES $4.5 MILLION IN NEW FUNDING
(bellicum.com) [
edit
]
BELLICUM PHARMACEUTICALS ANNOUNCES $3.75 MILLION IN FINANCING
(bellicum.com) [
edit
]
Edit This Page
Last Edited 11/4/09
Revision History
External Links
edit
Embed Widget
More
CrunchBase API
JSON Representation
of this page.
More API docs »
Sponsors
Become a Sponsor